1. 108OFactors predicting relapse in early breast cancer patients with a pathological complete response after neoadjuvant therapy: Pooled analysis based on the GBG database. (13th May 2019) Authors: Huober, J; Schneeweiss, A; Blohmer, J-U; Denkert, C; Hanusch, C; Jackisch, C; Nekljudova, V; Seither, F; Loibl, S; Untch, M Journal: Annals of oncology Issue: Volume 30(2019)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 188PDImpact of nab-paclitaxel dose reduction on survival of the randomized phase III GeparSepto trial comparing neoadjuvant chemotherapy of weekly nab-paclitaxel (nP) with solvent-based paclitaxel (P) followed by anthracycline/cyclophosphamide for patients with early breast cancer (BC). (23rd October 2018) Authors: Untch, M; Jackisch, C; Schneeweiss, A; Schmatloch, S; Aktas, B; Denkert, C; Schem, C; Wiebringhaus, H; Kümmel, S; Rhiem, K; Warm, M; Fasching, P A; Just, M; Hanusch, C; Hackmann, J; Blohmer, J-U; Furlanetto, J; Nekljudova, V; von Minckwitz, G; Loibl, S Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 243PGermline mutation status and therapy response in patients with triple-negative breast cancer (TNBC): Results of the GeparOcto study. (23rd October 2018) Authors: Pohl, E; Schneeweiss, A; Hauke, J; Moebus, V; Furlanetto, J; Denkert, C; Fasching, P A; Hanusch, C; Tesch, H; Weber-Lassalle, N; Müller, V; Rhiem, K; Untch, M; Luebbe, K; Lederer, B; Jackisch, C; Nekljudova, V; Schmutzler, R K; Hahnen, E; Loibl, S Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A randomised phase II study investigating durvalumab in addition to an anthracycline taxane-based neoadjuvant therapy in early triple-negative breast cancer: clinical results and biomarker analysis of GeparNuevo study. (16th May 2019) Authors: Loibl, S; Untch, M; Burchardi, N; Huober, J; Sinn, B V; Blohmer, J -U; Grischke, E -M; Furlanetto, J; Tesch, H; Hanusch, C; Engels, K; Rezai, M; Jackisch, C; Schmitt, W D; von Minckwitz, G; Thomalla, J; Kümmel, S; Rautenberg, B; Fasching, P A; Weber, K Journal: Annals of oncology Issue: Volume 30:Number 8(2019) Page Start: 1279 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗